Egle Therapeutics Appoints John Celebi as Chief Executive Officer
Egle Therapeutics Appoints John Celebi as Chief Executive Officer GlobeNewswire January 07, 2026 PARIS, Jan. 07, 2026 (GLOBE NEWSWIRE) — Egle Therapeutics SAS (Egle), a clinical-stage biotechnology company pioneering precision medicines that modulate regulatory T cells (Tregs) to rebalance immune function in patients with autoimmune diseases and cancer, today announced the appointment of John Celebi, […]